Quantcast

Latest Coronary artery disease Stories

2014-08-13 08:26:49

SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is "highly warranted" to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional...

2014-07-31 12:29:29

HARRISBURG, Pa., July 31, 2014 /PRNewswire/ -- The American Journal of Preventive Medicine (AJPM) recently published a study from United Concordia Dental that shows reduced hospitalizations and health care costs are possible when individuals with certain chronic conditions, or who are pregnant receive and maintain treatment for gum disease. "The results are in: oral wellness can help employers and their employees save money," said James Bramson, D.D.S., chief dental officer. "We're...

2014-07-23 16:28:13

Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 /PRNewswire/ -- Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent(TM) Paclitaxel-Coated PTCA Balloon Catheter. The Agent Drug-Coated Balloon (DCB) provides physicians with an...

2014-07-15 23:05:59

Okyanos Heart Institute and Perkins Healthcare Technologies Form Partnership to Enhance New Cardiac Stem Cell Therapy Cath Lab Freeport, Bahamas (PRWEB) July 15, 2014 Okyanos Heart Institute, a leader in cardiac adult stem cell therapy, has selected Perkins Healthcare Technologies to provide video integration solutions for its new state-of-the-art cardiac catheterization lab. The video integration system is paired with Phillips equipment, creating a top-grade comprehensive solution for...

healthy lifestyle reverses heart disease risk
2014-07-01 05:33:20

redOrbit Staff & Wire Reports - Your Universe Online Eliminating unhealthy habits such as losing weight and kicking the cigarette habit in your 30s and 40s could potentially reverse the natural progression of coronary artery disease, according to new research appearing in the June 30 edition of the journal Circulation. According to lead investigator Bonnie Spring, a professor of preventive medicine at the Northwestern University Feinberg School of Medicine, and her colleagues,...

2014-06-24 08:32:14

Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx(®) Ad5FGF-4, Cardium Therapeutics' angiogenic gene...

2014-06-19 14:30:02

American Heart Association Women  55 and younger are twice as likely to suffer a heart attack, die or require artery-opening procedures if they’re moderately or severely depressed, according to new research in the Journal of the American Heart Association. “Women in this age group are also more likely to have depression, so this may be one of the ‘hidden’ risk factors that can help explain why women die at a disproportionately higher rate than men after a heart attack,” said...

2014-06-12 08:30:19

SAN DIEGO, June 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), announced today that Cardium Therapeutics will announce interim results on the Generx(®) angiogenic gene therapy product candidate international ASPIRE Phase 3 registration study at the 2014 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 23-26 at the San Diego Convention Center...

2014-06-05 08:28:44

Chocolate® PTCA FDA clearance opens large new market opportunity SINGAPORE, June 5, 2014 /PRNewswire/ -- QT Vascular Ltd. (QT Vascular) is pleased to announce that on 4 June 2014, its wholly owned US subsidiary, TriReme Medical LLC, received notification from the United States Food and Drug Administration (FDA) of 510(K) clearance to market the Chocolate® PTCA Balloon Catheter (Chocolate PTCA) in the United States, for balloon dilatation of the stenotic portion of coronary artery...

2014-05-30 11:24:36

Georgia Institute of Technology A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile – based on a simple blood test – may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors. Researchers found the risk signature by comparing gene...


Latest Coronary artery disease Reference Libraries

Cardiac Stress Test
2012-11-18 19:30:13

The cardiac stress test is a diagnostic test used in Cardiac pathology for the purpose of patient diagnosis. It measures the heart’s function while placing a heavier workload on the heart. The cardiologist cannot be at the patient’s side while at work, under stress, during a workout or pushed to the limit so this test mimics those activities in a controlled setting. How it is Performed The stress is created by increasing the workload on the cardiac system. This can be accomplished by...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related